A study from the University of Alberta has identified genetic mutations in scleroderma patients, a finding that may lead to new...

Data collected from 21 melanoma referral centres in the U.S., Europe, and Australia reveals that, over the last five years, the use of...

A new study suggests that with current immunosuppressive therapies, 20% of people with early or at-risk dcSSc experienced worsening of skin.

An analysis of real-world data has evaluated the incidence, type and severity of skin-related side effects of immune checkpoint inhibitors.

A proof-of-principle study has found that fecal transplants may help advanced melanoma patients respond to immunotherapy better.